Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Cohort Study of Symptom Burden and Therapeutic Selection in Neuroendocrine Tumors (NETs)

NCT05064150 is registered in ClinicalTrials.gov with University of Iowa as lead sponsor.

NCT NCT05064150
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05064150 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Cohort Study of Symptom Burden and Therapeutic Selection in Neuroendocrine Tumors (NETs)
Lead sponsor
University of Iowa
Phase
Observational
Overall status
Active, not recruiting
Start date
May 10, 2022
Completion date
November 30, 2026
Enrollment
2,539 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

gastroenteropancreatic neuroendocrine tumor, lung neuroendocrine neoplasm, neuroendocrine carcinoma, neuroendocrine tumors